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Cystinosis is a lysosomal storage disease that is inherited in an autosomal recessive manner. Cystinosis, which is 
a lysosomal transport molecule needed to carry 
cystine out of the cells, is defective in this disease. 
This leads to the intracellular accumulation of 
the amino acid cystine in different organ tissues 
leading to multiple organ damage with subsequent 
failure. Infantile cystinosis is the most severe form. 
Infants appear normal at birth, but soon they fail 
to thrive and develop renal Fanconi syndrome, due 
to accumulation of cystine in the proximal tubules. 
Cystinosis is the most common cause of inherited 
Fanconi syndrome amongst Caucasians. This 
condition is frequently reported in the Caucasian 
population, but has never been reported in Oman. 
In this report, we describe the first case of infantile 
nephropathic cystinosis in Oman. Here, we will 
describe the clinical features, mainly renal and 
ophthalmological, and include a literature review of 
cystinosis in the Middle East. 
Case Report
A 21 month-old Omani girl was referred to Sultan 
Qaboos University Hospital for evaluation of severe 
failure to thrive. This was the second child born to 
first degree consanguineous parents at full term by 
spontaneous vaginal delivery. Her birth weight was 
2.8 Kg. According to the parents she was doing well 
until the age of 7 months, when she was noted by the 
primary care physician to be below the 3rd centile 
for both weight and height. At that point, it was 
felt that the failure to thrive was nutritional, since 
her mother gave history of exclusive breast feeding 
until the age of 7 months. Despite the nutritional 
advice and nutritional support for several months, 
the child did not gain weight and was referred to 
the Department of Child Health at Sultan Qaboos 
University Hospital at the age of 21 months with 
a weight of 5.36 Kgs. The mother gave a history 
of polyuria, which was suggested by the fact that 
she had 10 wet diapers per day, polydipsia and 
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ُّ الكلوي يْستينيِ اُء السيِ الدَّ
تسجيل احلالة األوىل يف  ُعمان
دانا النبهاين، حممد النجاري، رنا ال�ضناوي، الك�ضندر ت�ضاكو، اأنورادها غاني�س، ابت�ضام النور
َمات احَلالَّة التي تتميز  ِتزاِن يف اجُل�َضيرْ امللخ�ص: ُيعد الداء ال�ضي�ضتيني الكلوي من ال�ضطرابات ال�ضبغية اجل�ضدية املتنحية، وهو داُء الخرْ
برتاكم احلم�س الأميني )�ضي�ضتني( يف خمتلف الأجهزة والأن�ضجة. وميكن اأن يظهر الداء على �ضكل اأعرا�س كلوية اأوغريها. هناك ثلثة اأنواع 
من الداء ال�ضي�ضتيني ويكون الداء ال�ضي�ضتيني الكلوي الوليدي هو ال�ضكل الأكرث �ضدة. نقدم يف هذا التقرير امللمح ال�رسيرية املعهودة  من 
الداء ال�ضي�ضتيني الكلوي يف طفل ُعماين. ُتَعّد هذه احلالة نادرة جدا يف منطقة ال�رسق الأو�ضط، وهي  احلالة الوىل التي مت و�ضفها يف ُعمان.
ِتزاِن يف اجُل�َضيرَْمات احلاّلة، �ضي�ضتيامن، بلورات، تقرير حالة، ُعمان. مفتاح الكلمات: الداء ال�ضي�ضتيني، متلزمة فانكوين، داُء الخرْ
abstract: Cystinosis is an autosomal recessive, lysosomal storage disease characterised by the accumulation of 
the amino acid cystine in different organs and tissues. It is a multisystemic disease that can present with renal and 
extra renal manifestations. There are three types of cystinosis, infantile nephropathic cystinosis being the most 
severe form. In this report we present the classic clinical features of nephropathic cystinosis in an Omani child. 
This condition remains quite rare in the Middle East and is the first reported case of nephropathic cystinosis in the 
Omani population. 
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constipation since the age of 18 months. She had a 
voracious appetite. Developmentally, she was able 
to sit without support; however, she needed support 
for standing and walking. She had appropriate 
social development for her age. The family history 
was negative for similar conditions and for any renal 
or metabolic diseases. Also there was no history of 
miscarriages. On physical examination, the child 
was dark skinned, identical to her parents’ skin 
complexion. Her growth parameters were as follows: 
height 66 cm, weight 5.36 Kg, which are both below 
the 5th percentile; the head circumference was 
45.5 cm which was normal for her age. She did 
not have any dysmorphic features. She had frontal 
bossing and sparse, thin hair. She also had wide 
wrists, rachitic rosary, double malleoli and genu 
valgum. The abdomen was protuberant without 
organomegaly. The cardiovascular and respiratory 
examinations were normal. The initial blood 
investigations are summarised in Table 1. Urinalysis 
was positive for glucose (+2) and protein (+1) .The 
urine pH was 5, the specific gravity was 1.010 and 
the urine anion gap was positive. Urine reducing 
substances were negative. Urinary amino acid 
tests were done and showed significant elevation 
of all measured amino acids with the exception of 
aspartic acid, methionine, 1-methylhistidine, and 
turine. An indirect clue of this was the significantly 
elevated protein to creatinine ratio 106 mg/mmol 
(normal <50 mg/mmol) with mild proteinuria in 
the dipstick. The tubular reabsorption of phosphate 
was 55% (normal > 85%).
A wrist X-ray was obtained in view of the 
physical findings. This showed reduced bone 
density, widened metaphysis of the ulna and 
radius with cupping and fraying. No carpal bones 
were noted and the bone age was delayed [Figure 
1]. An abdominal ultrasound was also obtained 
and this showed normal intra-abdominal organs 
including two normal kidneys. She also underwent 
an ophthalmic examination that revealed normal 
visual acuity in both eyes. No strabismus, nystagmus 
or ocular motility disturbance was noted. However, 
slit lamp examination of the anterior segment of 
both eyes revealed fine, shiny crystal-like deposits 
diffusely distributed in the corneal epithelium and 
stroma. The surface of the epithelium was intact 
and the rest of the examination was unremarkable. 
The fundus examination showed no abnormal 
morphology of the disc, macula and vessels and a 
normal retinal background. With the presence of 
failure to thrive in a child with renal tubular acidosis 
and features of Fanconi syndrome, the ophthalmic 
findings of crystals in the cornea led to the diagnosis 
of cystinosis [Figure 2]. Retinopathy is usually a 
late finding of this condition and not seen in early 
childhood; it is preceded by corneal crystals. 
The child was started on supportive treatment 
Table 1: Results of the initial blood investigations
Test Patient result Reference range
Sodium 132 mmol/L 135–145 mmol/L
Potassium 3.1 mmol/L 3.5–6.1 mmol/L
Chloride 105 mmol/L 98–107 mmol/L
Bicarbonate 17 mmol/L 22–29 mmol/L
Creatinine 16 umol/L 15–31 umol/L
Urea 1.6 mmol/L 2.1–7.1 mmol/L
Anion gap 10 mmol/L 5–13 mmol/L
Total calcium 2.42 mmol/L 2.17–2.55 mmol/L
Corrected
Calcium
0.64 mmol/L 2.1–2.55 mmol/L
Phosphate 0.58 mmol/L 1.16–2.10 mmol/L
Alkaline 
phosphatase
841 units/L 0–281 units/L
Albumin 46 g/L 38–54 g/L
Parathyroid 
hormone
2.1 pmol/L 1.6–9.3 pmol/L
25-OH Vitamin D 55 nmol/L 22.5– 93.8 nmol/L
1,25 Vitamin D 45 pmol/L 40–140 pmol/L
 
Figure 1: Patient’s wrist X-ray showing reduced bone 
density, widened metaphysis of the ulna and radius with 
cupping and fraying.
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which included potassium citrate to correct the 
metabolic acidosis and hypokalemia, calcium 
sandoz, phosphate sandoz and alfacaclidol. 
Calcium was given for the severe hypocalcaemia. 
Also phosphate supplements were indicated due 
to severe hypophosphatemia. To avoid the risk of 
precipitation, a gap of at least four hours was left 
between each dose of the supplements. With this 
supportive treatment her weight increased to 
7.2 kg and she was able to progress on her motor 
development milestones. Cysteamine, which is a 
cystine depleting agent and the mainstay treatment 
for this disease, had to be ordered since it had never 
been used before in Oman. She was started on 
cysteamine 50 mg orally every 6 hrs (30 mg/kg/day) 
as soon as the medication was available. The aim 
was to increase the dose slowly to reach 50 mg/kg/
day over 4-6 weeks.
Discussion 
There are different types of cystinosis: 
the nephropathic and non-nephropathic. The 
nephropathic type has renal and extra renal 
manifestations. This can present in an infantile or 
late onset form. The infantile form is the most 
severe and, if left untreated, can lead to end 
stage renal disease by late childhood. The non-
nephropathic type presents with photophobia 
and only corneal cystine crystals without renal or 
systemic involvement. This type is also called ocular 
cystinosis.
Children with the infantile form appear normal 
at birth. The clinical picture becomes apparent 
between 3 and 6 months of age. The most common 
renal manifestation is the renal Fanconi syndrome 
due to renal proximal tubular dysfunction. This 
classically presents with failure to thrive, polyuria 
up to 2-3 litres/day, polydipsia, constipation, 
dehydration, weakness and hypophosphatemic 
rickets. Patients will also have glucosuria, 
proteinuria, phosphaturia, aminoaciduria and 
metabolic acidosis. 
Our patient presented at the age of 7 months 
with failure to thrive and had the classic features of 
renal Fanconi syndrome such as polyuria, polydipsia 
and constipation. She also had signs of rickets 
clinically, biochemically and radiologically. The 
laboratory investigations were also classic for renal 
Fanconi syndrome: normal anion gap, metabolic 
acidosis with hypokalemia and hypophosphatemia. 
She also had evidence of renal wasting of glucose 
which was suggested by normal serum glucose 
and a positive dipstick for glucose. The protein to 
creatinine ratio was quite elevated despite normal 
albumin and minimal proteinuria on dipstick. This 
suggests that the proteins lost are low molecular 
weight amino acids rather than the albumin which 
is a large molecular weight protein. She also had 
evidence of renal phosphate wasting suggested by 
hypophosphatemia and low tubular reabsorption of 
phosphate which was 55% (less than 85% indicates 
renal wasting).
The other manifestations of nephropathic 
cystinosis are extrarenal and present later on. 
These include myopathy and dysphagia due to 
accumulation of cystine in the muscles, endocrine 
involvement such as hypothyroidism and diabetes 
mellitus, hepatomegaly, hypersplenism and 
photophobia from the corneal accumulation of 
cystine in the cornea. Fundoscopy may show 
depigmentaion of the retina. Retinal changes may 
appear before the corneal features. The corneal 
crystals require slit lamp examination. These crystals 
are not present at birth; they appear between 16 and 
20 months of age,1,2 The corneal crystals are virtually 
pathognomonic. However, their absence does not 
exclude the diagnosis of cystinosis. Our patient had 
the typical crystal deposits in the cornea as seen in 
Figure 2.
Nephropathic cystinosis is the most common 
cause of renal Fanconi syndrome in the Caucasian 
population. This disease is quite rare in the Middle 
East. Only three Middle Eastern countries, Egypt, 
 
Figure 2: Photo of patient’s eye showing crystal deposits 
in the cornea typical of cystinosis.
Nephropathic Cystinosis 
First reported case in Oman
506 | SQU Medical Journal, November 2011, Volume 11, Issue 4
Saudi Arabia and Iran, have reported this disease 
in their populations.3-5 These studies have provided 
a lot of important information on nephropathic 
cystinosis in the region. Soliman et al., in the 
Egyptian study, were able to identify 16 patients with 
nephropathic cystinosis out of 33 who presented 
with Fanconi syndrome to a single centre.3 The 
Saudi study, by Aldahmesh et al., identified 8 
mutations, 4 of which were novel, in 21 patients with 
nephropathic cystinosis of Arab origin.5 The Iranian 
study by Mirdehghan et al. described the clinical 
features of  patients with nephropathic cystinosis 
presenting over a five year period to a single centre.4
The diagnosis of nephropathic cystinosis in this 
case was based on the presence of corneal cystine 
crystals in an infant with Fanconi syndrome. 
Traditionally, white blood cell cystine assay was 
the test of choice to confirm the diagnosis. This 
test is not available in Oman and it is costly and 
technically difficult to perform; there are only a 
few laboratories worldwide that can perform it. 
Currently, genetic testing by mutation analysis of 
the CTNS gene is a better alternative to confirm 
the diagnosis. It is necessary to consider sending 
samples to a specialised laboratory in case the 
diagnosis of nephropathic cystinosis is suspected in 
an infant younger than 20 months where the cystine 
crystals might not be present. Early treatment with 
cysteamine which is a cystine depleting agent can 
delay the progression to end stage renal disease.
Conclusion 
Given the high consanguinity rate in the Omani 
population, nephropathic cystinosis should be 
considered in any child presenting with Fanconi 
syndrome. Immediate referral to a tertiary hospital 
with nephrology and ophthalmology services is 
important to avoid delay in treatment. 
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